Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study

Backgrounds/Purpose The purpose of this study was to identify risk factors and establish a treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy. Methods The 443 patients who underwent PD from April 2006 to December...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepato-biliary-pancreatic sciences 2022-11, Vol.29 (11), p.1204-1213
Hauptverfasser: Yamaki, So, Satoi, Sohei, Yamamoto, Tomohisa, Hashimoto, Daisuke, Hirooka, Satoshi, Sakaguchi, Tatsuma, Masuda, Masataka, Shimatani, Masaaki, Ikeura, Tsukasa, Sekimoto, Mitsugu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1213
container_issue 11
container_start_page 1204
container_title Journal of hepato-biliary-pancreatic sciences
container_volume 29
creator Yamaki, So
Satoi, Sohei
Yamamoto, Tomohisa
Hashimoto, Daisuke
Hirooka, Satoshi
Sakaguchi, Tatsuma
Masuda, Masataka
Shimatani, Masaaki
Ikeura, Tsukasa
Sekimoto, Mitsugu
description Backgrounds/Purpose The purpose of this study was to identify risk factors and establish a treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy. Methods The 443 patients who underwent PD from April 2006 to December 2015 were analyzed. Clinical characteristics were compared between patients with and without clinical HJ stenosis, and risk factors for clinical HJ stenosis were analyzed. In addition, the treatment and clinical course of patients with clinical HJ stenosis were retrospectively reviewed. Results Clinical HJ stenosis defined with intrahepatic bile duct dilatation was identified in 40 patients (9.0%). Multivariate analysis revealed that the independent risk factor for clinical HJ stenosis was the hepatic duct at surgery ≤8 mm. Endoscopic HJ stenosis was identified in 36 patients, and 31 patients were treated successfully with double balloon endoscopic retrograde cholangiography; five patients required re‐anastomosis (n = 3) and percutaneous transhepatic biliary drainage (n = 2). Complete obstruction of HJ was found in five patients, and treatment with DB‐ERC was successful in only one patient. Conclusion The independent risk factor for clinical HJ stenosis was hepatic duct diameter ≤8 mm. Most cases of endoscopic HJ stenosis were treated successfully with DB‐ERC, except in patients with complete obstruction. Yamaki et al. identified clinical hepaticojejunostomy stenosis in 9.0% of cases after pancreaticoduodenectomy. The independent risk factor was a hepatic duct diameter ≤8 mm at surgery. Most cases of endoscopic hepaticojejunostomy stenosis were successfully treated with double‐balloon endoscopic retrograde cholangiography, except those with complete obstruction which required further invasive procedures.
doi_str_mv 10.1002/jhbp.1095
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2608535109</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2608535109</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3775-6d09563147312168c1c0bd2fee1fb82a5f33462bf8a3749c0f07d4772e02945b3</originalsourceid><addsrcrecordid>eNp1kU2O1DAQhS0EYkbNLLgAssQGFs34J4kddsMIGNBIIATryLHLtEPaDrbDKDuOwGE4ESfBoZtZIOGNS6XPr8rvIfSQkmeUEHY-7PqpVG19B51S2cht00p297YW1Qk6S2kg5XDKW07uoxNeScla2Zyinx9c-oKt0jnEhJU3OEdQeQ8-45SjyvB5wTZErEfnnVYj3sGkstPh1_cfAwyzDymH_VJgKKVL2IB1Hgy-cXmHnS8axxe4dyNgM-uMjRtVLr3gsbIZIp6U1-vcomvmYMCDXlWf4wscIceQptJw36CMmc3yAN2zakxwdrw36NOrlx8vr7bX716_uby43mouRL1tTHGl4bQSnDLaSE016Q2zANT2kqnacl41rLdScVG1mlgiTCUEA8Laqu75Bj056E4xfJ0h5W7vkoZxVB7CnDrWEFnzuphf0Mf_oEOYoy_bdUzUnDWiLWts0NMDpcuXUgTbTdHtVVw6Sro1zW5Ns1vTLOyjo-Lc78Hckn-zK8D5Abgpvi7_V-reXr14_0fyN9ourwM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2753267947</pqid></control><display><type>article</type><title>Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Yamaki, So ; Satoi, Sohei ; Yamamoto, Tomohisa ; Hashimoto, Daisuke ; Hirooka, Satoshi ; Sakaguchi, Tatsuma ; Masuda, Masataka ; Shimatani, Masaaki ; Ikeura, Tsukasa ; Sekimoto, Mitsugu</creator><creatorcontrib>Yamaki, So ; Satoi, Sohei ; Yamamoto, Tomohisa ; Hashimoto, Daisuke ; Hirooka, Satoshi ; Sakaguchi, Tatsuma ; Masuda, Masataka ; Shimatani, Masaaki ; Ikeura, Tsukasa ; Sekimoto, Mitsugu</creatorcontrib><description>Backgrounds/Purpose The purpose of this study was to identify risk factors and establish a treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy. Methods The 443 patients who underwent PD from April 2006 to December 2015 were analyzed. Clinical characteristics were compared between patients with and without clinical HJ stenosis, and risk factors for clinical HJ stenosis were analyzed. In addition, the treatment and clinical course of patients with clinical HJ stenosis were retrospectively reviewed. Results Clinical HJ stenosis defined with intrahepatic bile duct dilatation was identified in 40 patients (9.0%). Multivariate analysis revealed that the independent risk factor for clinical HJ stenosis was the hepatic duct at surgery ≤8 mm. Endoscopic HJ stenosis was identified in 36 patients, and 31 patients were treated successfully with double balloon endoscopic retrograde cholangiography; five patients required re‐anastomosis (n = 3) and percutaneous transhepatic biliary drainage (n = 2). Complete obstruction of HJ was found in five patients, and treatment with DB‐ERC was successful in only one patient. Conclusion The independent risk factor for clinical HJ stenosis was hepatic duct diameter ≤8 mm. Most cases of endoscopic HJ stenosis were treated successfully with DB‐ERC, except in patients with complete obstruction. Yamaki et al. identified clinical hepaticojejunostomy stenosis in 9.0% of cases after pancreaticoduodenectomy. The independent risk factor was a hepatic duct diameter ≤8 mm at surgery. Most cases of endoscopic hepaticojejunostomy stenosis were successfully treated with double‐balloon endoscopic retrograde cholangiography, except those with complete obstruction which required further invasive procedures.</description><identifier>ISSN: 1868-6974</identifier><identifier>EISSN: 1868-6982</identifier><identifier>DOI: 10.1002/jhbp.1095</identifier><identifier>PMID: 34882986</identifier><language>eng</language><publisher>Japan: Wiley Subscription Services, Inc</publisher><subject>Bile ducts ; double balloon endoscopic retrograde cholangiography ; Endoscopy ; hepatico‐jejunostomy stenosis ; intrahepatic bile duct dilatation ; Ostomy ; Pancreaticoduodenectomy ; risk factor ; Risk factors</subject><ispartof>Journal of hepato-biliary-pancreatic sciences, 2022-11, Vol.29 (11), p.1204-1213</ispartof><rights>2021 Japanese Society of Hepato‐Biliary‐Pancreatic Surgery</rights><rights>2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery.</rights><rights>Copyright © 2022 Japanese Society of Hepato‐Biliary‐Pancreatic Surgery</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3775-6d09563147312168c1c0bd2fee1fb82a5f33462bf8a3749c0f07d4772e02945b3</citedby><cites>FETCH-LOGICAL-c3775-6d09563147312168c1c0bd2fee1fb82a5f33462bf8a3749c0f07d4772e02945b3</cites><orcidid>0000-0001-6527-5409 ; 0000-0001-6178-7984 ; 0000-0002-7880-889X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjhbp.1095$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjhbp.1095$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34882986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamaki, So</creatorcontrib><creatorcontrib>Satoi, Sohei</creatorcontrib><creatorcontrib>Yamamoto, Tomohisa</creatorcontrib><creatorcontrib>Hashimoto, Daisuke</creatorcontrib><creatorcontrib>Hirooka, Satoshi</creatorcontrib><creatorcontrib>Sakaguchi, Tatsuma</creatorcontrib><creatorcontrib>Masuda, Masataka</creatorcontrib><creatorcontrib>Shimatani, Masaaki</creatorcontrib><creatorcontrib>Ikeura, Tsukasa</creatorcontrib><creatorcontrib>Sekimoto, Mitsugu</creatorcontrib><title>Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study</title><title>Journal of hepato-biliary-pancreatic sciences</title><addtitle>J Hepatobiliary Pancreat Sci</addtitle><description>Backgrounds/Purpose The purpose of this study was to identify risk factors and establish a treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy. Methods The 443 patients who underwent PD from April 2006 to December 2015 were analyzed. Clinical characteristics were compared between patients with and without clinical HJ stenosis, and risk factors for clinical HJ stenosis were analyzed. In addition, the treatment and clinical course of patients with clinical HJ stenosis were retrospectively reviewed. Results Clinical HJ stenosis defined with intrahepatic bile duct dilatation was identified in 40 patients (9.0%). Multivariate analysis revealed that the independent risk factor for clinical HJ stenosis was the hepatic duct at surgery ≤8 mm. Endoscopic HJ stenosis was identified in 36 patients, and 31 patients were treated successfully with double balloon endoscopic retrograde cholangiography; five patients required re‐anastomosis (n = 3) and percutaneous transhepatic biliary drainage (n = 2). Complete obstruction of HJ was found in five patients, and treatment with DB‐ERC was successful in only one patient. Conclusion The independent risk factor for clinical HJ stenosis was hepatic duct diameter ≤8 mm. Most cases of endoscopic HJ stenosis were treated successfully with DB‐ERC, except in patients with complete obstruction. Yamaki et al. identified clinical hepaticojejunostomy stenosis in 9.0% of cases after pancreaticoduodenectomy. The independent risk factor was a hepatic duct diameter ≤8 mm at surgery. Most cases of endoscopic hepaticojejunostomy stenosis were successfully treated with double‐balloon endoscopic retrograde cholangiography, except those with complete obstruction which required further invasive procedures.</description><subject>Bile ducts</subject><subject>double balloon endoscopic retrograde cholangiography</subject><subject>Endoscopy</subject><subject>hepatico‐jejunostomy stenosis</subject><subject>intrahepatic bile duct dilatation</subject><subject>Ostomy</subject><subject>Pancreaticoduodenectomy</subject><subject>risk factor</subject><subject>Risk factors</subject><issn>1868-6974</issn><issn>1868-6982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kU2O1DAQhS0EYkbNLLgAssQGFs34J4kddsMIGNBIIATryLHLtEPaDrbDKDuOwGE4ESfBoZtZIOGNS6XPr8rvIfSQkmeUEHY-7PqpVG19B51S2cht00p297YW1Qk6S2kg5XDKW07uoxNeScla2Zyinx9c-oKt0jnEhJU3OEdQeQ8-45SjyvB5wTZErEfnnVYj3sGkstPh1_cfAwyzDymH_VJgKKVL2IB1Hgy-cXmHnS8axxe4dyNgM-uMjRtVLr3gsbIZIp6U1-vcomvmYMCDXlWf4wscIceQptJw36CMmc3yAN2zakxwdrw36NOrlx8vr7bX716_uby43mouRL1tTHGl4bQSnDLaSE016Q2zANT2kqnacl41rLdScVG1mlgiTCUEA8Laqu75Bj056E4xfJ0h5W7vkoZxVB7CnDrWEFnzuphf0Mf_oEOYoy_bdUzUnDWiLWts0NMDpcuXUgTbTdHtVVw6Sro1zW5Ns1vTLOyjo-Lc78Hckn-zK8D5Abgpvi7_V-reXr14_0fyN9ourwM</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Yamaki, So</creator><creator>Satoi, Sohei</creator><creator>Yamamoto, Tomohisa</creator><creator>Hashimoto, Daisuke</creator><creator>Hirooka, Satoshi</creator><creator>Sakaguchi, Tatsuma</creator><creator>Masuda, Masataka</creator><creator>Shimatani, Masaaki</creator><creator>Ikeura, Tsukasa</creator><creator>Sekimoto, Mitsugu</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6527-5409</orcidid><orcidid>https://orcid.org/0000-0001-6178-7984</orcidid><orcidid>https://orcid.org/0000-0002-7880-889X</orcidid></search><sort><creationdate>202211</creationdate><title>Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study</title><author>Yamaki, So ; Satoi, Sohei ; Yamamoto, Tomohisa ; Hashimoto, Daisuke ; Hirooka, Satoshi ; Sakaguchi, Tatsuma ; Masuda, Masataka ; Shimatani, Masaaki ; Ikeura, Tsukasa ; Sekimoto, Mitsugu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3775-6d09563147312168c1c0bd2fee1fb82a5f33462bf8a3749c0f07d4772e02945b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bile ducts</topic><topic>double balloon endoscopic retrograde cholangiography</topic><topic>Endoscopy</topic><topic>hepatico‐jejunostomy stenosis</topic><topic>intrahepatic bile duct dilatation</topic><topic>Ostomy</topic><topic>Pancreaticoduodenectomy</topic><topic>risk factor</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamaki, So</creatorcontrib><creatorcontrib>Satoi, Sohei</creatorcontrib><creatorcontrib>Yamamoto, Tomohisa</creatorcontrib><creatorcontrib>Hashimoto, Daisuke</creatorcontrib><creatorcontrib>Hirooka, Satoshi</creatorcontrib><creatorcontrib>Sakaguchi, Tatsuma</creatorcontrib><creatorcontrib>Masuda, Masataka</creatorcontrib><creatorcontrib>Shimatani, Masaaki</creatorcontrib><creatorcontrib>Ikeura, Tsukasa</creatorcontrib><creatorcontrib>Sekimoto, Mitsugu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepato-biliary-pancreatic sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamaki, So</au><au>Satoi, Sohei</au><au>Yamamoto, Tomohisa</au><au>Hashimoto, Daisuke</au><au>Hirooka, Satoshi</au><au>Sakaguchi, Tatsuma</au><au>Masuda, Masataka</au><au>Shimatani, Masaaki</au><au>Ikeura, Tsukasa</au><au>Sekimoto, Mitsugu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study</atitle><jtitle>Journal of hepato-biliary-pancreatic sciences</jtitle><addtitle>J Hepatobiliary Pancreat Sci</addtitle><date>2022-11</date><risdate>2022</risdate><volume>29</volume><issue>11</issue><spage>1204</spage><epage>1213</epage><pages>1204-1213</pages><issn>1868-6974</issn><eissn>1868-6982</eissn><abstract>Backgrounds/Purpose The purpose of this study was to identify risk factors and establish a treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy. Methods The 443 patients who underwent PD from April 2006 to December 2015 were analyzed. Clinical characteristics were compared between patients with and without clinical HJ stenosis, and risk factors for clinical HJ stenosis were analyzed. In addition, the treatment and clinical course of patients with clinical HJ stenosis were retrospectively reviewed. Results Clinical HJ stenosis defined with intrahepatic bile duct dilatation was identified in 40 patients (9.0%). Multivariate analysis revealed that the independent risk factor for clinical HJ stenosis was the hepatic duct at surgery ≤8 mm. Endoscopic HJ stenosis was identified in 36 patients, and 31 patients were treated successfully with double balloon endoscopic retrograde cholangiography; five patients required re‐anastomosis (n = 3) and percutaneous transhepatic biliary drainage (n = 2). Complete obstruction of HJ was found in five patients, and treatment with DB‐ERC was successful in only one patient. Conclusion The independent risk factor for clinical HJ stenosis was hepatic duct diameter ≤8 mm. Most cases of endoscopic HJ stenosis were treated successfully with DB‐ERC, except in patients with complete obstruction. Yamaki et al. identified clinical hepaticojejunostomy stenosis in 9.0% of cases after pancreaticoduodenectomy. The independent risk factor was a hepatic duct diameter ≤8 mm at surgery. Most cases of endoscopic hepaticojejunostomy stenosis were successfully treated with double‐balloon endoscopic retrograde cholangiography, except those with complete obstruction which required further invasive procedures.</abstract><cop>Japan</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34882986</pmid><doi>10.1002/jhbp.1095</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-6527-5409</orcidid><orcidid>https://orcid.org/0000-0001-6178-7984</orcidid><orcidid>https://orcid.org/0000-0002-7880-889X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1868-6974
ispartof Journal of hepato-biliary-pancreatic sciences, 2022-11, Vol.29 (11), p.1204-1213
issn 1868-6974
1868-6982
language eng
recordid cdi_proquest_miscellaneous_2608535109
source Wiley Online Library Journals Frontfile Complete
subjects Bile ducts
double balloon endoscopic retrograde cholangiography
Endoscopy
hepatico‐jejunostomy stenosis
intrahepatic bile duct dilatation
Ostomy
Pancreaticoduodenectomy
risk factor
Risk factors
title Risk factors and treatment strategy for clinical hepatico‐jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T23%3A49%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20and%20treatment%20strategy%20for%20clinical%20hepatico%E2%80%90jejunostomy%20stenosis%20defined%20with%20intrahepatic%20bile%20duct%20dilatation%20after%20pancreaticoduodenectomy:%20A%20retrospective%20study&rft.jtitle=Journal%20of%20hepato-biliary-pancreatic%20sciences&rft.au=Yamaki,%20So&rft.date=2022-11&rft.volume=29&rft.issue=11&rft.spage=1204&rft.epage=1213&rft.pages=1204-1213&rft.issn=1868-6974&rft.eissn=1868-6982&rft_id=info:doi/10.1002/jhbp.1095&rft_dat=%3Cproquest_cross%3E2608535109%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2753267947&rft_id=info:pmid/34882986&rfr_iscdi=true